AI assistant
Sending…
Roivant Sciences Ltd. — Director's Dealing 2020
Sep 4, 2020
30587_dirs_2020-09-04_3bf10238-10c2-4525-a79c-2cc85b374ecf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immunovant, Inc. (IMVT)
CIK: 0001764013
Period of Report: 2020-09-04
Reporting Person: Roivant Sciences Ltd. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-04 | Common Stock, $0.0001 par value per share | P | 380000 | $33.00 | Acquired | 47593419 | Direct |
More from Roivant Sciences Ltd.
Registration Form
2026
May 20
Annual Report
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 25
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 18